The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2015

Filed:

Sep. 07, 2012
Applicants:

Gurvinder Singh Rekhi, Suwanee, GA (US);

Richard Sidwell, Cumming, GA (US);

Sharon Hamm, Atlanta, GA (US);

Inventors:

Gurvinder Singh Rekhi, Suwanee, GA (US);

Richard Sidwell, Cumming, GA (US);

Sharon Hamm, Atlanta, GA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/54 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 31/403 (2006.01); A61K 31/4745 (2006.01); A61K 31/58 (2006.01); A61K 31/704 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5084 (2013.01); A61K 31/403 (2013.01); A61K 31/4745 (2013.01); A61K 31/58 (2013.01); A61K 31/704 (2013.01); A61K 9/5026 (2013.01); A61K 9/5078 (2013.01);
Abstract

The invention relates to a controlled release composition comprising a combination of isosorbide dinitrate and hydralazine, such as hydralazine hydrochloride, that in operation delivers the drug in a pulsed or multi-modal manner for the treatment of angina, ischaemic heart disease, arterial hypertension and related disease conditions. Preferably, the isosorbide dinitrate and hydralazine hydrochloride can be released from the dosage form in an erodable, diffusion and/or osmotic-controlled release profile.


Find Patent Forward Citations

Loading…